A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects
Clinical trial NCT01920399 · COMPLETED
Trial details
- NCT number
- NCT01920399
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.